New trends in the development of opioid peptide analogues as advanced remedies for pain relief.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Current Topics in Medicinal Chemistry

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.2174/1568026043451663PMID 14754374
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cyclic morphiceptin analogs: cyclization studies and opioid activities in vitro.

  2009cited by this paper
• Lipid membrane permeability of modified c[D-Pen2, D-Pen5]enkephalin peptides.

  2009cited by this paper
• Coumarinic Acid-Based Cyclic Prodrugs of Opioid Peptides that Exhibit Metabolic Stability to Peptidases and Excellent Cellular Permeability

  2004cited by this paper
• Acyloxyalkoxy-Based Cyclic Prodrugs of Opioid Peptides: Evaluation of the Chemical and Enzymatic Stability as Well as Their Transport Properties Across Caco-2 Cell Monolayers

  2004cited by this paper
• International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels

  2003cited by this paper
• Synthesis and biological activities of cyclic lanthionine enkephalin analogues : δ-opioid receptor selective ligands

  2002cited by this paper
• In vitro quantitative study of the degradation of endomorphins.

  2002cited by this paper
• Endomorphin-1 Analogues Containing β-Proline Are μ-Opioid Receptor Agonists and Display Enhanced Enzymatic Hydrolysis Resistance

  2002cited by this paper
• Non-peptide opioid receptor ligands - recent advances. Part I - agonists.

  2002cited by this paper
• Interaction of enkephalin peptides with anionic model membranes.

  2002cited by this paper
• Endomorphins, Met-enkephalin, Tyr-MIF-1, and the P-glycoprotein efflux system.

  2002cited by this paper
• Transport and metabolism of opioid peptides across BeWo cells, an in vitro model of the placental barrier.

  2002cited by this paper
• [Dmt(1)]DALDA is highly selective and potent at mu opioid receptors, but is not cross-tolerant with systemic morphine.

  2002cited by this paper
• Dissociation of pharmacological pro- and anti-opioid effects by neuropeptide FF analogs.

  2002cited by this paper
• Current prodrug strategies via membrane transporters/receptors

  2002cited by this paper
• New reagents, reactions, and peptidomimetics for drug design.

  2002cited by this paper
• Synthesis and biological activities of cyclic lanthionine enkephalin analogues: delta-opioid receptor selective ligands.

  2002cited by this paper
• Biological Activity of Dermorphin and Deltorphin-II Analogs Replaced Phenylalanine at Position 3 by 2,6-Dimethylphenylalanine

  2002cited by this paper
• Synthesis and biological activities of YkFA analogues: effects of position 4 substitutions and altered ring size on in vitro opioid activity.

  2002cited by this paper
• Dermorphin and deltorphin heptapeptide analogues: replacement of Phe residue by Dmp greatly improves opioid receptor affinity and selectivity.

  2002cited by this paper
• Design of nonpeptides from peptide ligands for peptide receptors.

  2002cited by this paper
• Design, synthesis, and evaluation of opioid analogues with non-peptidic beta-turn scaffold: enkephalin and endomorphin mimetics.

  2002cited by this paper
• Opioid tolerance-in search of the holy grail.

  2002cited by this paper
• Determination of transport in the Caco-2 cell assay of compounds varying in lipophilicity using LC-MS: enhanced transport of Leu-enkephalin analogues.

  2002cited by this paper
• Side chain modifications change the binding and agonist properties of endomorphin 2.

  2002cited by this paper
• Saturable brain-to-blood transport of endomorphins

  2001cited by this paper
• Regulations of opioid dependence by opioid receptor types.

  2001cited by this paper
• C-Terminal glycine is crucial for hyperalgesic activity of nociceptin/orphanin FQ-(1-6).

  2001cited by this paper
• Bestatin as an experimental tool in mammals.

  2001cited by this paper
• Peptide drug modifications to enhance bioavailability and blood-brain barrier permeability.

  2001cited by this paper
• Rubiscolin, a δ selective opioid peptide derived from plant Rubisco

  2001cited by this paper
• Synthesis, biology, NMR and conformation studies of the topographically constrained delta-opioid selective peptide analogs of [beta-iPrPhe(3)]deltorphin I.

  2001cited by this paper
• Pseudoproline-containing analogues of morphiceptin and endomorphin-2: evidence for a cis Tyr-Pro amide bond in the bioactive conformation.

  2001cited by this paper
• Spinorphin, an endogenous inhibitor of enkephalin-degrading enzymes, potentiates leu-enkephalin-induced anti-allodynic and antinociceptive effects in mice.

  2001cited by this paper
• Study of the Enzymatic Degradation of Endomorphin Analogs Containing α, α-Disubstituted Glycine

  2001cited by this paper
• Probing opioid receptor-ligand interactions by employment of indolizidin-9-one amino acid as a constrained Gly(2)-Gly(3) surrogate in a leucine-enkephalin mimic.

  2001cited by this paper
• Antinociceptive effect produced by intracerebroventricularly administered dynorphin A is potentiated by p-hydroxymercuribenzoate or phosphoramidon in the mouse formalin test.

  2001cited by this paper
• Carboxyl terminal peptides derived from prepro-orphanin FQ/nociceptin (ppOFQ/N) are produced in the hypothalamus and possess analgesic bioactivities.

  2001cited by this paper
• Stereospecific synthesis of (2S)-2-methyl-3-(2',6'-dimethyl-4'-hydroxyphenyl)-propionic acid (Mdp) and its incorporation into an opioid peptide.

  2001cited by this paper
• Dynorphin A analogs containing a conformationally constrained phenylalanine derivative in position 4: reversal of preferred stereochemistry for opioid receptor affinity and discrimination of kappa vs. delta receptors.

  2001cited by this paper
• DALDA analogues containing alpha-hydroxymethylamino acids.

  2001cited by this paper
• MDR1 P-glycoprotein transports endogenous opioid peptides.

  2001cited by this paper
• Studies on the antinociceptive effect of [Nphe1]nociceptin(1-13)NH2 in mice.

  2001cited by this paper
• Pharmacodynamic and pharmacokinetic characterization of poly(ethylene glycol) conjugation to met-enkephalin analog [D-Pen2, D-Pen5]-enkephalin (DPDPE).

  2001cited by this paper
• beta-Peptides: from structure to function.

  2001cited by this paper
• Effects of intracerebroventricularly administered chimeric peptide of metenkephalin and FMRFa--[D-Ala2]YFa-on antinociception and its modulation in mice.

  2001cited by this paper
• Opioids in chronic pain.

  2001cited by this paper
• The opioid peptide analogue biphalin induces less physical dependence than morphine.

  2001cited by this paper
• Improved blood-brain barrier penetration and enhanced analgesia of an opioid peptide by glycosylation.

  2001cited by this paper
• Endogenous opiates: 2000.

  2001cited by this paper
• Influence of degradation on binding properties and biological activity of endomorphin 1.

  2001cited by this paper
• Strategies to manage the adverse effects of oral morphine: an evidence-based report.

  2001cited by this paper
• Biological properties of Phe(o)-opioid peptide analogues.

  2001cited by this paper
• Rubiscolin, a delta selective opioid peptide derived from plant Rubisco.

  2001cited by this paper
• Highly potent side‐chain to side‐chain cyclized enkephalin analogues containing a carbonyl bridge: synthesis, biology and conformation

  2001cited by this paper
• Natural peptide analgesics: the role of solution conformation

  2001cited by this paper
• The outstanding biological stability of beta- and gamma-peptides toward proteolytic enzymes: an in vitro investigation with fifteen peptidases.

  2001cited by this paper
• Pharmacological characterization of the dermorphin analog [Dmt(1)]DALDA, a highly potent and selective mu-opioid peptide.

  2001cited by this paper
• Opioid Peptides and Their Glycoconjugates: Structure-Activity Relationships

  2001cited by this paper
• [2',6'-Dimethyltyrosine]dynorphin A(1-11)-NH2 analogues lacking an N-terminal amino group: potent and selective kappa opioid antagonists.

  2001cited by this paper
• The Outstanding Biological Stability of β‐ and γ‐Peptides toward Proteolytic Enzymes: An In Vitro Investigation with Fifteen Peptidases

  2001cited by this paper
• Role of endogenous opioid system in the regulation of the stress response

  2001cited by this paper
• Synthesis and binding activity of endomorphin-1 analogues containing β-amino acids

  2000cited by this paper
• Interleukin-2: Structural and Biological Relatedness to Opioid Peptides

  2000cited by this paper
• Antinociceptive activity of [beta-methyl-2', 6'-dimethyltyrosine(1)]-substituted cyclic [D-Pen(2), D-Pen(5)]Enkephalin and [D-Ala(2),Asp(4)]Deltorphin analogs.

  2000cited by this paper
• Insulin enhancement of opioid peptide transport across the blood-brain barrier and assessment of analgesic effect.

  2000cited by this paper
• Enkephalin glycopeptide analogues produce analgesia with reduced dependence liability.

  2000cited by this paper
• Assessment of Stereoselectivity of Trimethylphenylalanine Analogues of δ‐Opioid [D‐Pen2,D‐Pen5]‐Enkephalin

  2000cited by this paper
• [Pro(3)]Dyn A(1-11)-NH(2): a dynorphin analogue with high selectivity for the kappa opioid receptor.

  2000cited by this paper
• Synthesis and binding properties of endomorphin-2 analogs containing α-hydroxymethyl amino acids

  2000cited by this paper
• Pain modulation: expectation, opioid analgesia and virtual pain.

  2000cited by this paper
• Selective antagonism by naloxonazine of antinociception by Tyr-D-Arg-Phe-beta-Ala, a novel dermorphin analogue with high affinity at mu-opioid receptors.

  2000cited by this paper
• Endomorphin-1 induces antinociception without immunomodulatory effects in the rat

  2000cited by this paper
• Chemical and enzymatic stability as well as transport properties of a Leu-enkephalin analogue and ester prodrugs thereof.

  2000cited by this paper
• Beta-casomorphins: substitution of phenylalanine with beta-homo phenylalanine increases the mu-type opioid receptor affinity.

  2000cited by this paper
• β-Casomorphins: substitution of phenylalanine with β-homo phenylalanine increases the μ-type opioid receptor affinity

  2000cited by this paper
• Synthesis and binding activity of endomorphin-1 analogues containing beta-amino acids.

  2000cited by this paper
• Cyclopropane-derived peptidomimetics. Design, synthesis, and evaluation of novel enkephalin analogues.

  2000cited by this paper
• Modifications of the cyclic mu receptor selective tetrapeptide Tyr-c[D-Cys-Phe-D-Pen]NH2 (Et): effects on opioid receptor binding and activation.

  2000cited by this paper
• Effects of peptidase inhibitors on anti-nociceptive action of dynorphin-(1–8) in rats

  2000cited by this paper
• Characterization of tynorphin, a potent endogenous inhibitor of dipeptidyl peptidaseIII.

  2000cited by this paper
• A substance P-opioid chimeric peptide as a unique nontolerance-forming analgesic.

  2000cited by this paper
• Improved bioavailability to the brain of glycosylated Met-enkephalin analogs.

  2000cited by this paper
• Non-opioid antinociceptive effects of supraspinal histogranin and related peptides: possible involvement of central dopamine D(2) receptor.

  2000cited by this paper
• Organic anion-transporting polypeptides mediate transport of opioid peptides across blood-brain barrier.

  2000cited by this paper
• Stability of the Disulfide Bond in an Avidin-Biotin Linked Chimeric Peptide During in vivo Transcytosis Through Brain Endothelial Cells

  2000cited by this paper
• The opioid-receptor-like 1 (ORL-1) as a potential target for new analgesics.

  2000cited by this paper
• Development of Novel Lipophilic Derivatives of DADLE (Leucine Enkephalin Analogue): Intestinal Permeability Characteristics of DADLE Derivatives in Rats

  2000cited by this paper
• Synthesis and in vitro opioid activity profiles of DALDA analogues.

  2000cited by this paper
• Stereochemical requirements for receptor recognition of the mu-opioid peptide endomorphin-1.

  2000cited by this paper
• Tetrapeptide derivatives of [D-Pen(2),D-Pen(5)]-enkephalin (DPDPE) lacking an N-terminal tyrosine residue are agonists at the mu-opioid receptor.

  2000cited by this paper
• Novel ligands lacking a positive charge for the delta- and mu-opioid receptors.

  2000cited by this paper
• Inhibition of morphine tolerance development by a substance P-opioid peptide chimera.

  2000cited by this paper
• Complete inhibition of purinoceptor agonist-induced nociception by spinorphin, but not by morphine.

  2000cited by this paper
• Optically active aromatic amino acids. Part VI. Synthesis and properties of [Leu5]‐enkephalin analogues containing O‐methyl‐L‐tyrosine1 with ring substitution at position 3′

  2000cited by this paper
• Dissociation of analgesic and rewarding effects of endomorphin-1 in rats.

  2000cited by this paper
• Synthesis of stereoisomeric analogues of endomorphin-2, H-Tyr-Pro-Phe-Phe-NH(2), and examination of their opioid receptor binding activities and solution conformation.

  2000cited by this paper
• Assessment of stereoselectivity of trimethylphenylalanine analogues of delta-opioid [D-Pen(2),D-Pen(5)]-enkephalin.

  2000cited by this paper
• Differential cardiorespiratory effects of endomorphin 1, endomorphin 2, DAMGO, and morphine.

  2000cited by this paper
• Conformational and topographical considerations in designing agonist peptidomimetics from peptide leads.

  2000cited by this paper

• Isolation and Purification of Antioxidant Peptides from Fermented Hydrolysates of Sheep Brain Proteins

  2025cites this paper
• Analgesic Peptides: From Natural Diversity to Rational Design

  2024cites this paper
• Chemical Behavior and Bioactive Properties of Spinorphin Conjugated to 5,5′-Dimethyl- and 5,5′-Diphenylhydantoin Analogs

  2024cites this paper
• In Situ Forming, Enzyme-Responsive Peptoid-Peptide Hydrogels: An Advanced Long-Acting Injectable Drug Delivery System

  2024cites this paper
• Design of κ-Opioid Receptor Agonists for the Development of Potential Treatments of Pain with Reduced Side Effects

  2023cites this paper
• PD-1: A new candidate target for analgesic peptide design.

  2023cites this paper
• Novel Cyclic Endomorphin Analogues with Multiple Modifications and Oligoarginine Vector Exhibit Potent Antinociception with Reduced Opioid-like Side Effects.

  2021cites this paper
• Endomorphin-2 Analog Inhibits the Growth of DLD-1 and RKO Human Colon Cancer Cells by Inducing Cell Apoptosis

  2020cites this paper
• The influence of the stereochemistry and C-end chemical modification of dermorphin derivatives on the peptide-phospholipid interactions.

  2020cites this paper
• Dynamic Kinetic Cross-Electrophile Arylation of Benzyl Alcohols by Nickel Catalysis.

  2020cites this paper
• Potential of Nociceptin/Orphanin FQ Peptide Analogs for Drug Development

  2020cites this paper
• Food-Derived Opioid Peptides in Human Health: A Review

  2020cites this paper
• Cyclizing Painkillers: Development of Backbone-Cyclic TAPS Analogs

  2020cites this paper
• On resin click-chemistry-mediated synthesis of novel enkephalin analogues with potent anti-nociceptive activity

  2019cites this paper
• Novel Dimethyltyrosine-Tetrahydroisoquinoline Peptidomimetics with Aromatic Tetrahydroisoquinoline Substitutions Show In Vitro Kappa and Mu Opioid Receptor Agonism.

  2019cites this paper
• Organometallic Chemistry at the Interface with Biology

  2019cites this paper
• Antinociceptive activity of thiazole-containing cyclized DAMGO and Leu-(Met) enkephalin analogs.

  2019cites this paper
• Endomorphin-2 analogs containing modified tyrosines: Biological and theoretical investigation of the influence on conformation and pharmacological profile.

  2019cites this paper
• Biochemical and pharmacological characterization of three opioid‐nociceptin hybrid peptide ligands reveals substantially differing modes of their actions

  2018cites this paper
• Recent progress in non-opioid analgesic peptides.

  2018cites this paper
• Physicochemical Properties for Potential Alzheimer’s Disease Drugs

  2017cites this paper
• Tryptophan-Containing Non-Cationizable Opioid Peptides - a new chemotype with unusual structure and in vivo activity.

  2017cites this paper
• Endomorphins: Promising Endogenous Opioid Peptides for the Development of Novel Analgesics

  2017cites this paper
• Pharmacological Potential of the Endogenous Dipeptide Kyotorphin and Selected Derivatives

  2017cites this paper
• Peptidomimetics I

  2017influential citation
• Structure‐constrained endomorphin analogs display differential antinociceptive mechanisms in mice after spinal administration

  2017cites this paper
• Radiomitigation and Tissue Repair Activity of Systemically Administered Therapeutic Peptide TP508 Is Enhanced by PEGylation

  2017cites this paper
• Potent μ-Opioid Receptor Agonists from Cyclic Peptides Tyr-c[D-Lys-Xxx-Tyr-Gly]: Synthesis, Biological, and Structural Evaluation.

  2016cites this paper
• Food Proteins as Source of Opioid Peptides-A Review.

  2016cites this paper
• Synthesis and Evaluation of Mixed Efficacy Mu Opioid Receptor (MOR), Delta Opioid Receptor (DOR) Peptidomimetic Ligands.

  2016cites this paper
• Side Chain Cyclized Aromatic Amino Acids: Great Tools as Local Constraints in Peptide and Peptidomimetic Design.

  2016cites this paper
• Biphalin: The Foundation of Bivalent Ligands.

  2016cites this paper
• Endomorphin-1 analogues (MELs) penetrate the bloodebrain barrier and exhibit good analgesic effects with minimal side effects.

  2015cites this paper
• NMR spectroscopy: a useful tool for drugs development and monitoring biological reactions

  2015cites this paper
• Rational approach to the design of bioactive peptidomimetics: Recent developments in opioid agonist peptides

  2015cites this paper
• Sensitive and selective determination of peptides, PG and PGP, using a novel fluorogenic reagent 4-chlorobenzene-1,2-diol

  2015cites this paper
• Strategies to Improve Bioavailability and In Vivo Efficacy of the Endogenous Opioid Peptides Endomorphin-1 and Endomorphin-2.

  2015cites this paper
• Beta-endorphin biotransformation and modulation of inflammatory signals

  2015cites this paper
• Quantum Chemical and Molecular Docking Studies of [(η6-Cp*Rh-Tyr1)-Leu-enkephalin]2+ to G-Protein-Coupled μ-, ∂-, and κ-Opioid Receptors and Comparisons to the Neuropeptide [Tyr1]-Leu-enkephalin: Conformations, Noncovalent Amino Acid Binding Sites, Binding Energies, Electronic Factors, and Receptor

  2015cites this paper
• Azepinone-Constrained Amino Acids in Peptide and Peptidomimetic Design

  2015cites this paper
• Synthesis and biological evaluation of compact, conformationally constrained bifunctional opioid agonist - neurokinin-1 antagonist peptidomimetics.

  2015cites this paper
• Advances in Peptides as Therapeutic Drugs.

  2015cites this paper
• Endomorphin-1 analogues (MELs) penetrate the blood-brain barrier and exhibit good analgesic effects with minimal side effects.

  2015cites this paper
• Evaluation of Analgesic and Anti -inflammatory Activity of Moringa stenopetala Bak.(Moringaceae) in Mice

  2014cites this paper
• Novel cyclic biphalin analogue with improved antinociceptive properties.

  2014cites this paper
• Easy preparation of dehydroalanine building blocks equipped with oxazolidin-2-one chiral auxiliaries, and applications to the stereoselective synthesis of substituted tryptophans

  2014cites this paper
• Hybrid opioid/non-opioid ligands in pain research.

  2014cites this paper
• Cyclic side-chain-linked opioid analogs utilizing cis- and trans-4-aminocyclohexyl-D-alanine.

  2014cites this paper
• Synthesis of tripeptides containing D-Trp substituted at the indole ring, assessment of opioid receptor binding and in vivo central antinociception.

  2014cites this paper
• Design and synthesis of pyrimidine molecules endowed with thiazolidin-4-one as new anticancer agents.

  2014cites this paper
• Cyclic endomorphin analogs in targeting opioid receptors to achieve pain relief.

  2014cites this paper
• Endomorphin derivatives with improved pharmacological properties.

  2013cites this paper
• Side-effects of analgesic kyotorphin derivatives: advantages over clinical opioid drugs

  2013cites this paper
• Challenges for Pain Management in the Twenty-First Century

  2013cites this paper
• Lipid- and sugar-modified endomorphins: novel targets for the treatment of neuropathic pain

  2013cites this paper
• Cyclization in opioid peptides.

  2013cites this paper
• Preparation and evaluation at the delta opioid receptor of a series of linear leu-enkephalin analogues obtained by systematic replacement of the amides.

  2013cites this paper
• Characterization of N-Boc/Fmoc/Z-N'-formyl-gem-diaminoalkyl derivatives using electrospray ionization multi-stage mass spectrometry.

  2013cites this paper
• Design and physicochemical characterization of poly(amidoamine) nanoparticles and the toxicological evaluation in human endothelial cells: applications to peptide delivery to the brain

  2013cites this paper
• UNIVERSIDADE DE SÃO PAULO INSTITUTO DE QUÍMICA Programa de Pós-Graduação em Ciências Biológicas (Bioquímica)

  2013cites this paper
• Bioavailability of endomorphins and the blood-brain barrier--a review.

  2013cites this paper
• Synthesis and biological evaluation of an orally active glycosylated endomorphin-1.

  2012cites this paper
• Selective and sensitive determination of peptides using 3,4-dihydroxyphenylacetic acid as a fluorogenic reagent.

  2012cites this paper
• Factors that restrict the cell permeation of cyclic prodrugs of an opioid peptide, part 3: Synthesis of analogs designed to have improved stability to oxidative metabolism.

  2012cites this paper
• Lipo-Endomorphin-1 Derivatives with Systemic Activity against Neuropathic Pain without Producing Constipation

  2012cites this paper
• Addressing the Interactions between Opioid Ligands and Their Receptors

  2012cites this paper
• Synthesis, biological activity and structure-activity relationship of endomorphin-1/substance P derivatives.

  2012cites this paper
• Synthesis of Modified Phenylalanine Peptides by Cross Enyne Metathesis and a Diels–Alder Reaction as Key Steps

  2012cites this paper
• In vivo antinociception of potent mu opioid agonist tetrapeptide analogues and comparison with a compact opioid agonist - neurokinin 1 receptor antagonist chimera

  2012cites this paper
• The chemoselective reactions of tyrosine-containing G-protein-coupled receptor peptides with [Cp*Rh(H2O)3](OTf)2, including 2D NMR structures and the biological consequences.

  2012cites this paper
• Molecular docking of opiates and opioid peptides, a tool for the design of selective agonists and antagonists, and for the investigation of atypical ligand-receptor interactions.

  2012cites this paper
• Endomorphins: potential roles and therapeutic indications in the development of opioid peptide analgesic drugs

  2012cites this paper
• Development of neuropeptide drugs that cross the blood-brain barrier

  2011cites this paper
• Neurotoxicity and neuroprotective effects of Polyimides (PI) and Polyphenylenevinylene (PPV) against Hydrogen Peroxide (H2O2) / Norfaezah Mazalan ... [et al.]

  2011cites this paper
• Desirability function combining metabolic stability and functionality of peptides

  2011cites this paper
• Low Molecular Weight Opioid Peptide Esters Could be Developed as a New Class of Analgesics

  2011cites this paper
• Abstracts of Papers

  2011cites this paper
• Turning Endogenous Peptides into New Analgesics: The Example of Kyotorphin Derivatives

  2011cites this paper
• Intranasal delivery of neuropeptides.

  2011cites this paper
• Stereoselective palladium-catalyzed allylic alkylations of peptide amide enolates.

  2011cites this paper
• The Inverse Type II β‐Turn on D‐Trp‐Phe, a Pharmacophoric Motif for MOR Agonists

  2011cites this paper
• Peptides: important tools for the treatment of central nervous system disorders.

  2011cites this paper
• Development of opioid peptide analogs for pain relief.

  2010cites this paper
• A simple route towards peptide analogues containing substituted (S)- or (R)-tryptophans

  2010cites this paper
• SYNTHESIS OF ESTRONE-OPIOID PEPTIDE ANALOGUE WITH EXPECTED ANALGESIC ACTIVITY

  2010cites this paper
• Synthesis of Analogues Based on the Opioid Alkaloid Mitragynine

  2010cites this paper
• Chemical modifications designed to improve peptide stability: incorporation of non-natural amino acids, pseudo-peptide bonds, and cyclization.

  2010cites this paper
• Synthesis and biological evaluation of cyclic endomorphin-2 analogs

  2010cites this paper
• Delivery of peptide and protein drugs over the blood-brain barrier.

  2009cites this paper
• Positional scanning for peptide secondary structure by systematic solid-phase synthesis of amino lactam peptides.

  2009cites this paper
• Synthesis and in vitro Evaluation of Trifluoroethylamine Analogues of Enkephalins

  2009cites this paper
• A structure-activity relationship study and combinatorial synthetic approach of C-terminal modified bifunctional peptides that are delta/mu opioid receptor agonists and neurokinin 1 receptor antagonists.

  2008cites this paper
• Multiple ligands in opioid research.

  2008cites this paper
• Improving the Biopharmaceutical Properties of Cyclic Opioid Peptide Prodrugs

  2008cites this paper
• The Utility of Oligopeptidase in Brain-Targeting Delivery of an Enkephalin Analogue by Prodrug Design

  2008cites this paper
• SELECTIVE NON-PEPTIDE MU-OPIOID RECEPTOR ANTAGONIST: DESIGN, SYNTHESIS AND BIOLOGICAL STUDIES

  2008cites this paper
• Synthesis and in vitro evaluation of a library of modified endomorphin 1 peptides.

  2008cites this paper
• Re-discussion of the importance of ionic interactions in stabilizing ligand-opioid receptor complex and in activating signal transduction.

  2007cites this paper
• Topological exploration of cyclic endomorphin-1 analogues, structurally defined models for investigating the bioactive conformation of MOR agonists.

  2007cites this paper
• Design, Synthesis, and Biological Evaluation of Novel Bifunctional C-Terminal-Modified Peptides for δ/μ Opioid Receptor Agonists and Neurokinin-1 Receptor Antagonists

  2007cites this paper